Literature DB >> 8340398

Human cystatin D. cDNA cloning, characterization of the Escherichia coli expressed inhibitor, and identification of the native protein in saliva.

J P Freije1, M Balbín, M Abrahamson, G Velasco, H Dalbøge, A Grubb, C López-Otín.   

Abstract

A cDNA coding for cystatin D, a human member of the cystatin protein family, has been cloned after specific amplification of reverse-transcribed parotid gland RNA. After replacing the segment encoding the putative 20-residue signal peptide with one encoding the Escherichia coli OmpA leader sequence, the cDNA was expressed in E. coli. The isolated recombinant protein exhibited Ki values of 1.2 nM and > 1 microM for papain and cathepsin B, respectively. An antiserum raised against recombinant cystatin D recognized a protein in human saliva with electrophoretical mobility identical to that of the recombinant protein. Immunoenzymatic analysis revealed that this cysteine proteinase inhibitor is present in human saliva and tears at concentrations of 3.8 and 0.5 mg/liter, respectively, while it was not detected in seminal plasma, blood plasma, milk, or cerebrospinal fluid. Cystatin D purified from human saliva by immunosorption displayed a heterogeneous N-terminal end, with sequences starting at residues 5, 7, 9, and 11 of the predicted N-terminal portion of the mature protein. On the basis of structural and functional properties, cystatin D represents a novel cysteine proteinase inhibitor possibly playing a protective role against proteinases present in the oral cavity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8340398

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Low-level internalization of cystatin E/M affects legumain activity and migration of melanoma cells.

Authors:  Hanna Wallin; Jenny Apelqvist; Freddi Andersson; Ulf Ekström; Magnus Abrahamson
Journal:  J Biol Chem       Date:  2017-06-19       Impact factor: 5.157

2.  Cystatin D is a candidate tumor suppressor gene induced by vitamin D in human colon cancer cells.

Authors:  Silvia Alvarez-Díaz; Noelia Valle; José Miguel García; Cristina Peña; José M P Freije; Víctor Quesada; Aurora Astudillo; Félix Bonilla; Carlos López-Otín; Alberto Muñoz
Journal:  J Clin Invest       Date:  2009-08       Impact factor: 14.808

3.  Genetic polymorphisms of the CST2 locus coding for cystatin SA.

Authors:  M Shintani; K Minaguchi; S Isemura; E Saitoh; K Sanada; T Semba
Journal:  Hum Genet       Date:  1994-07       Impact factor: 4.132

4.  Quantitative salivary proteomic differences in oral chronic graft-versus-host disease.

Authors:  Carol W Bassim; Kiran S Ambatipudi; Jacqueline W Mays; Dean A Edwards; Stephan Swatkoski; Helen Fassil; Kristin Baird; Marjan Gucek; James E Melvin; Steven Z Pavletic
Journal:  J Clin Immunol       Date:  2012-07-18       Impact factor: 8.317

5.  Cystatin D, a natural salivary cysteine protease inhibitor, inhibits coronavirus replication at its physiologic concentration.

Authors:  A R Collins; A Grubb
Journal:  Oral Microbiol Immunol       Date:  1998-02

6.  Murine monoclonal antibody which can distinguish cystatins SA1 and SA2.

Authors:  Taichi Ito; Akiyo Komiya-Ito; Katsuji Okuda; Kiyoshi Minaguchi; Eiichi Saitoh; Satoru Yamada; Tetsuo Kato
Journal:  Mol Immunol       Date:  2005-01-08       Impact factor: 4.407

Review 7.  Cystatin C--properties and use as diagnostic marker.

Authors:  A O Grubb
Journal:  Adv Clin Chem       Date:  2000       Impact factor: 5.394

8.  Cystatin E/M suppresses legumain activity and invasion of human melanoma.

Authors:  Jon J Briggs; Mads H Haugen; Harald T Johansen; Adam I Riker; Magnus Abrahamson; Øystein Fodstad; Gunhild M Maelandsmo; Rigmor Solberg
Journal:  BMC Cancer       Date:  2010-01-15       Impact factor: 4.430

9.  Secreted cystatins decrease proliferation and enhance apoptosis of human leukemic cells.

Authors:  Samar Hunaiti; Hanna Wallin; Mia Eriksson; Marcus Järås; Magnus Abrahamson
Journal:  FEBS Open Bio       Date:  2020-09-23       Impact factor: 2.792

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.